A carregar...
Publicação
An analysis of pharmaceutical industry pain points- the case of Portugal
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 478.35 KB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
This study identifies the problem areas of the pharmaceutical industry in three European
countries: Belgium, Italy, and Portugal. It examines the disparities in healthcare systems
between the countries and what difficulties they are experiencing in becoming more patient focused.
Some issues are common to the countries. Yet, they are weighed differently according to the
country's characteristics, mainly economic power. The pharmaceutical industry in Portugal
has undergone consistent growth, making substantial contributions to both the nation's
economic advancement and healthcare domain.
In general, these countries are making progress in prioritizing patients, paving the way for
personalized medicines and better disease management. These developments promise
substantial benefits in treatment outcomes.
Descrição
Palavras-chave
Healthcare Pharmaceutical industry Pain points Pricing and reimbursement Approval of medicines Measure of outcomes and value Pharmaceutical patents Sustainability Patient treatment compliance